US Bancorp’s Albireo Pharma Inc ALBO Stock Holding History

US Bancorp’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,669	Closed	-$57.7K	–	4243
2022 Q4	$57.7K	Buy	2,669 +220	+9%	+$4.65K	﹤0.01%	2452
2022 Q3	$47K	Sell	2,449 -134	-5%	-$2.77K	﹤0.01%	2581
2022 Q2	$51K	Buy	2,583 +716	+38%	+$18.9K	﹤0.01%	2573
2022 Q1	$56K	Sell	1,867 -44	-2%	-$1.29K	﹤0.01%	2565
2021 Q4	$44K	Hold	1,911	–	–	﹤0.01%	2728
2021 Q3	$59K	Sell	1,911 -65	-3%	-$2.01K	﹤0.01%	2570
2021 Q2	$70K	Sell	1,976 -38	-2%	-$1.24K	﹤0.01%	2495
2021 Q1	$71K	Sell	2,014 -118	-6%	-$4.36K	﹤0.01%	2444
2020 Q4	$80K	Buy	2,132 +227	+12%	+$8.26K	﹤0.01%	2320
2020 Q3	$63K	Buy	1,905 +1,804	+1,786%	+$52.5K	﹤0.01%	2304
2020 Q2	$3K	Buy	+101	New	+$2.38K	﹤0.01%	3462

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

US Bancorp's ALBO Position: Q1 2023 in Review

US Bancorp sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 2,669 shares — an estimated $57.7K sold.

US Bancorp first reported a position in ALBO in Q2 2020 and held it in 11 quarters. The position peaked at $80K in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

US Bancorp reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
US Bancorp sold 2,669 Albireo Pharma Inc shares in Q1 2023, an estimated $57.7K.
US Bancorp first reported a position in Albireo Pharma Inc in Q2 2020 and held it in 11 quarters.
US Bancorp's Albireo Pharma Inc position peaked at $80K in Q4 2020.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on US Bancorp's 13F filing for Q1 2023, filed 9 May 2023.